A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma

BACKGROUND: 5-fluorouracil, leucovorin, irinotecan and oxaliplatin (FOLFIRINOX) is superior to gemcitabine in patients with metastatic pancreatic cancer who have a good performance status. We investigated this combination as neoadjuvant therapy for locally advanced pancreatic cancer (LAPC). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosein, Peter J, Macintyre, Jessica, Kawamura, Carolina, Maldonado, Jennifer Cudris, Ernani, Vinicius, Loaiza-Bonilla, Arturo, Narayanan, Govindarajan, Ribeiro, Afonso, Portelance, Lorraine, Merchan, Jaime R, Levi, Joe U, Rocha-Lima, Caio M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404979/
https://www.ncbi.nlm.nih.gov/pubmed/22642850
http://dx.doi.org/10.1186/1471-2407-12-199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404979/
https://www.ncbi.nlm.nih.gov/pubmed/22642850
http://dx.doi.org/10.1186/1471-2407-12-199

Ejemplares similares